2013 Annual Meeting | Neurologic Issues in Pregnancy

Date Thursday 03/21/13

Time 12:00 PM - 04:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Kathleen B. Digre, MD, FAAN

Topic(s) Women's Issues

Learning Objectives Participants should understand physiological changes in pregnancy that can affect the nervous system or its vasculature. Participants should be able to recommend safe options for imaging in pregnancy and recommend safe options for symptomatic and prophylactic treatment of headaches during pregnancy; understand work-up, management, and treatment of the pregnant patient with stroke and multiple sclerosis; understand the risks of seizures and various antiepileptic drug regimens during pregnancy; and understand the challenges in treating myasthenia in pregnancy.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
12:00 PM - 12:05 PM		Introductions Kathleen B. Digre, MD, FAAN
12:05 PM - 12:35 PM		Physiological Changes in Pregnancy That Affect the Brain and Nervous System Michael Varner
12:35 PM - 01:05 PM		Epilepsy and Pregnancy Autumn Klein, MD, PhD
01:05 PM - 01:25 PM		Headaches in Pregnancy Kathleen B. Digre, MD, FAAN
01:25 PM - 01:40 PM		Questions and Answers
01:40 PM - 01:50 PM		Break
01:50 PM - 02:30 PM		Multiple Sclerosis and Pregnancy Patricia K. Coyle, MD, FAAN
02:30 PM - 03:00 PM		Vascular Disorders Kathleen B. Digre, MD, FAAN
03:00 PM - 03:20 PM		Myasthenia and Neuromuscular Disorders Michael Varner
03:20 PM - 03:40 PM		Straight from the Clinic--Cases Autumn Klein, MD, PhD
03:40 PM - 04:00 PM		Questions and Answers and Discussion

Faculty Disclosures
Patricia K. Coyle, MD, FAAN	Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Company. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Celgene.
Kathleen B. Digre, MD, FAAN	Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care.
Autumn Klein, MD, PhD	No disclosure on file
Michael Varner	No disclosure on file

��ɫ��

��ɫ��